Clival Database

Power BI Dashboard
Free Trial/Demo
Client Login

About Us
Clinical Trial Data
Glossary Terms Drug Development Process Therapy Area/ Disease Sponsor/ Organisation Orphan Drug Designation Fast Track Approval Breakthrough Approval
Licensing Opportunities
CRO
News Center
Pricing
Contact Us

Home
Clinical Trial Update

Clinical Trial Update

Recent News

Everest Medicin...

March 11,2022 12:40 PM

SciSparc Launch...

March 11,2022 12:38 PM

Health Canada A...

March 11,2022 12:37 PM

Cerveau Technol...

March 11,2022 12:34 PM

Lupin Launches ...

March 11,2022 12:33 PM

Everest Medicines Announces That Licensing Partner Venatorx Pharmaceuticals Reports Positive Results From Pivotal Phase 3 Cefepime-Taniborbactam Trial
March 11,2022 12:40 PM

Pfizer Begins Phase 2/3 Study Of Novel Covid-19 Oral Treatment In Paediatric Participants
March 10,2022 11:55 AM

Aldeyra Therapeutics Initiates Phase 2 Clinical Trial Of ADX-2191 For The Treatment Of Retinitis Pigmentosa
March 09,2022 10:39 AM

Kintor Pharma Completes Patient Enrollment In Phase II Trial Of KX-826 In China To Treat Female Patients With Androgenetic Alopecia
March 09,2022 10:30 AM

Kintor Pharma Announces Completion Of Patient Enrollment In Phase II Clinical Trial Of KX-826 In China For The Treatment Of Androgenetic Alopecia In F
March 08,2022 10:43 AM

Elgans Infant Malabsorption Treatment Reduces Complications In Phase III
March 03,2022 10:59 AM

Elgan Pharma Announces Positive Results From Its Phase III Study Of ELGN-GI In Preterm Infants For Treatment Of Intestinal Malabsorption
March 03,2022 10:54 AM

PolyPid Announces 750th Patient Enrolled In SHIELD I Phase 3 Clinical Trial Of D-PLEX₁₀₀ In Abdominal Surgery
March 03,2022 10:47 AM

Pfizers Phase 3 CLOVER Trial Of Clostridioides Difficile Vaccine Fails To Meet Its Pre-specified Primary Endpoint Of Prevention Of Primary CDI
March 02,2022 10:26 AM

SAB Biotherapeutics Reports Update To Phase 3 NIH ACTIV-2 Trial Design Evaluating SAB-185 For Covid-19 Treatment
March 01,2022 10:04 AM

Transcenta Announces First Patient Dosed In Phase IIa Study Of Claudin18.2 Monoclonal Antibody TST001 Combined With Cisplatin And Gemcitabine For The
February 28,2022 10:40 AM

Arrowhead Concludes Enrolment In Phase IIb Mixed Dyslipidemia Trial
February 28,2022 10:25 AM

Bayer Begins Phase II CONFIDENCE Study Of Initial Combo Therapy Of Finerenone With Empagliflozin In Patients With CKD & Type 2 Diabetes
February 28,2022 10:14 AM

US FDA Clears Armata Pharmas IND Application To Start Phase 2 Trial Of AP-PA02 In Non-cystic Fibrosis Bronchiectasis
February 25,2022 10:32 AM

Primary Endpoint Met In Phase III Clinical Trial Of Trilaciclib In Chinese Patients With Small Cell Lung Cancer
February 25,2022 10:29 AM

Ayala Pharmaceuticals Announces Completion Of Enrollment In Part A Of RINGSIDE, A Pivotal Phase 2/3 Study Of AL102 In Desmoid TumorsInterim Results Ex
February 24,2022 10:26 AM

Innovent Announces First Patient Dosed With CD73 Antibody In Phase 1a/1b Clinical Trial For Advanced Solid Tumor
February 24,2022 10:23 AM

Arrowhead Starts Phase I/II Trial Of Complement-mediated Disease Asset
February 23,2022 10:44 AM

Aslans Shot At Approval Jumps In Gastric Cancer After Phase II/III Completion
February 23,2022 10:38 AM

InnoCare Begins Patient Dosing In Phase II Trial Using Orelabrutinib For ITP Treatment
February 23,2022 10:04 AM

Valbiotis Gets Approval To Launch Two Phase II/III INSIGHT & INSIGHT 2 Studies On TOTUM 854 For The Reduction Of Blood Pressure
February 21,2022 10:18 AM

Philogen Gets France ANSM Nod To Begin New A Phase II Study To Evaluate Nidlegy In Several Non-melanoma Skin Cancers
February 21,2022 10:14 AM

Phase III Trials Of COVID Drug Movfor Show Positive Results, Says Hetero
February 21,2022 10:11 AM

Covaxin To Be Evaluated As COVID19 Vaccine Candidate In US As USFDA Lifts Clinical Hold
February 21,2022 10:05 AM

OliPass Announces Commencement Of Dosing In Phase 2a Trial For Pain Killer OLP-1002
February 21,2022 09:55 AM

ZielBio Begins Patient Dosing In Phase 1/2 Trial Of ZB131 In Patients With Solid Tumours
February 18,2022 10:20 AM

Zealand Pharma Completes Patient Enrollment In Phase 3 Trial Of Dasiglucagon In Children With Congenital Hyperinsulinism
February 16,2022 10:14 AM

Biohaven And Pfizer Announce Positive Topline Results Of Pivotal Trial Of Rimegepant For The Acute Treatment Of Migraine In China And South Korea
February 15,2022 10:36 AM

Kintor Pharma Announces First Patient Dosing In China In Phase III Clinical Trial Of Proxalutamide For The Treatment Of COVID-19 Outpatients
February 12,2022 10:20 AM

Global Roundup Celltrion Prepares To Trap COVID-19 In Phase III
February 11,2022 10:13 AM

Revolo Bio Gets UK MHRA Nod For Two Phase 2 Trials Of 1805 In Autoimmune Diseases
February 08,2022 09:51 AM

Celltrion Submits Investigational New Drug (IND) Application To Initiate A Global Phase III Clinical Trial Evaluating An Inhaled COVID-19 Antibody Coc
February 08,2022 09:34 AM

Antengene Announces HREC Approval In Australia For The Phase I Trial Of The Small Molecule CD73 Inhibitor ATG-037
February 07,2022 10:29 AM

HUTCHMED Initiates Phase Ib/II Study Of HMPL-453 In Combination With Chemotherapy Or Toripalimab For Advanced Solid Tumors In China
February 07,2022 10:04 AM

Vanda Pharma Phase III Study Of Tradipitant In Gastroparesis Fails To Meet Prespecified Primary Endpoint
February 07,2022 09:54 AM

Eli Lilly Nixes Verzenios Phase 3 HER2-positive Early Breast Cancer Trial
February 04,2022 11:01 AM

EuBiologics Phase III Clinical Trial IND Approval Of EuCorVac-19, COVID-19 Vaccine Candidate In South Korea
February 04,2022 10:48 AM

Kintor Pharma Announces Dosing Of First Subject In US Phase I Clinical Trial Of GT20029 For Androgenic Alopecia And Acne
February 04,2022 10:46 AM

Viracta Therapeutics Begins Patient Dosing In Phase 1b/2 Trial Of Nana-val In Patients With Advanced Epstein-Barr Virus-positive Solid Tumours
February 02,2022 11:15 AM

Eli Lilly Incyte Announce Updates On Phase 3 Development Programme For Olumiant In Adults With Active Systemic Lupus Erythematosus
January 31,2022 10:40 AM

Yamo Pharma Begins Patient Enrollment In Phase 2 Study Of L1-79 In Autism Spectrum Disorder
January 31,2022 10:35 AM

Todos Medical And NLC Pharma Announce Primary And Secondary Endpoints Met In NLC-V-01 Phase 2 Clinical Trial Of Oral Antiviral 3CL Protease Inhibitor
January 28,2022 10:59 AM

Sun Pharma Gets SEC Nod For Phase III Clinical Trial For Antipsychotic Drug Pimavanserin
January 27,2022 10:48 AM

Hope Medicine Announces US FDA Clearance For Phase II Clinical Trial Of A First-in-class Monoclonal Antibody, HMI-115, In Androgen Alopecia
January 27,2022 10:35 AM

RemeGens Telitacicept Demonstrates Positive Results In Phase II Trial In Treatment Of Primary Sjögrens Syndrome
January 25,2022 10:16 AM

Ascletis Begins Patient Dosing In Phase III Trial Of FASN Inhibitor ASC40 In Combo With Bevacizumab To Treat Recurrent Glioblastoma
January 25,2022 10:04 AM

Ascletis Announces First Patient Dosed In The Phase III Clinical Trial Of FASN Inhibitor ASC40 Combined With Bevacizumab For Treatment Of Recurrent Gl
January 24,2022 10:49 AM

Innovent, Eli Lilly Announce Final Clinical Results And Biomarker Analysis Of Phase Ib Study Of Tyvyt Plus Bevacizumab Biosimilar Injection For Advanc
January 24,2022 10:21 AM

Merck And Eisai Share Crucial Phase 3 Trial Results For Advanced Endometrial Carcinoma Treatment
January 22,2022 11:11 AM

Provention Bio Announces Initiation Of The Phase 2a PREVAIL-2 Study Of PRV-3279 CD32B × CD79 Bispecific DART® Molecule In Systemic Lupus Erythematos
January 21,2022 10:46 AM

Elpiscience Announces First Patient Dosed In US Phase I Clinical Trial Of Anti-CD39 Monoclonal Antibody ES002 For Treatment Of Advanced Solid Tumors
January 21,2022 10:22 AM

HUTCHMED Initiates A Phase I Trial Of HMPL-653 In Patients With Advanced Malignant Solid Tumors And TGCT In China
January 21,2022 10:21 AM

Sanofi Regeneron Announce Second Phase 3 Trial Of Dupixent To Treat Prurigo Nodularis Met Primary And Key Secondary Endpoints
January 20,2022 10:53 AM

Neurophth Therapeutics Receives IND Clearance To Initiate Clinical Trial For China AAV-ND4 Gene Therapy NR082 In Leber Hereditary Optic Neuropathy
January 20,2022 10:35 AM

Kinnate Biopharma Inc Announces FDA Clearance Of Investigational Drug Application For KIN-3248
January 20,2022 10:32 AM

Second Positive Phase III Trial For Dupixent® (dupilumab) In The Treatment Of Nodular Prurigo, With Significant Improvements For Patients
January 19,2022 11:34 AM

CStone EQRx S Sugemalimab Scores OS Win In First-line Lung Cancer Trial
January 19,2022 11:17 AM

Pieris Pharma Begins Patient Dosing In Phase 2 Gastric Cancer Trial Of 4–1BB/HER2 Bispecific Cinrebafusp Alfa
January 18,2022 10:26 AM

Green Valley Obtains IND Approval From US FDA For Sodium Oligomannates Global Phase II Clinical Trial In Treating Parkinsons Disease
January 18,2022 10:11 AM

RedHill Biopharma Announces Positive Results From Phase 2/3 Study Of Oral Opaganib To Treat Severely Ill Hospitalized Covid-19 Patients
January 17,2022 10:09 AM

I-Mab Announces First Patient Dosed In China Phase 2 Clinical Trial Of Efineptakin Alfa In Combination With Pembrolizumab In Advanced Solid Tumors
January 13,2022 10:19 AM

Pfizer Announces Positive Results From Phase 3 Study Exploring Coadministration Of Prevnar 20 With Pfizer-BioNTech Covid-19 Vaccine In Older Adults
January 13,2022 09:49 AM

Ascletis Announces First Patient Dosed In The Phase II Clinical Trial Of ASC42, An In-House Developed, Best-in-Class FXR Agonist For Chronic Hepatitis
January 12,2022 10:19 AM

BioMarin Announces Positive Results From Phase 3 GENEr8-1 Study Of Valoctocogene Roxaparvovec To Treat Severe Haemophilia A
January 12,2022 09:49 AM

HUTCHMED Initiates Phase I Study Of BTK Inhibitor HMPL-760 In Patients With Previously Treated B-Cell Non-Hodgkin Lymphoma In China
January 11,2022 10:06 AM

SciSparc Begins Patient Recruitment In Phase IIa Trial Of SCI-110 To Treat Alzheimers Disease
January 11,2022 10:00 AM

Novartis, Molecular Partners Announce EMPATHY Phase 2 Study For Ensovibep, A DARPin Antiviral Therapeutic For Covid-19 Meets Primary Endpoint
January 11,2022 09:53 AM

Akesos Cadonilimab Pd-1/Ctla-4 Bi-Specific Antibody Combined With Ivonescimab Obtained Approval To Initiate A Phase Ib/Ii Clinical Trial
January 07,2022 10:02 AM

BioRestorative Awarded An STTR Phase I Grant To Explore Therapeutic Effects Of PEG-peptide Hydrogel-encapsulated Hypoxic Bone Marrow Stem Cells
January 06,2022 10:53 AM

Bharat Biotech Asked To Conduct Phase III Trials For Its Intranasal Vaccine
January 05,2022 11:28 AM

Gannex Announces Completion Of The US Phase I Trial Of ASC43F An In House Developed First In Class Dual Targeting Fixed Dose Combination Tablet For NA
January 04,2022 10:23 AM

Kintor Pharma Announces First Patient Dosing Of Phase III Clinical Trial Of KX-826 Pyrilutamide For Treating Androgenic Alopecia Patients In China
January 03,2022 03:27 PM

Bio Thera Solutions Announces Initiation Of Phase I Clinical Trials For BAT6026 A Monoclonal Antibody Targeting OX40
December 30,2021 11:01 AM

Moleculin Announces Preliminary Third Cohort Interim Data In Phase 1b/2 Trial Of Annamycin To Treat Soft Tissue Sarcoma Lung Metastases
December 30,2021 10:18 AM

RIBOMIC Announces Preliminary Topline Data From Phase 2 Trials Of RBM-007 For Wet Age-Related Macular Degeneration
December 29,2021 10:55 AM

Akesos IL-17A Monoclonal Antibody (Gumokimab) Completion Of Patient Enrollment In Phase II Clinical Trial For The Treatment Of Ankylosing Spondylitis
December 29,2021 10:18 AM

I-Mab Announces IND Approval From China NMPA For Phase 2 Clinical Trial Of Enoblituzumab In Combination With Pembrolizumab In Solid Tumors
December 28,2021 11:05 AM

PharmAbcine Announces First Patient Enrolled And Dosed In The Phase II Clinical Trial For The Treatment Of MTNBC
December 28,2021 10:17 AM

Accutar Biotechnology Announces FDA Approval Of IND Application For Phase 1 Clinical Trial Of AC0176 For Prostate Cancer
December 27,2021 10:55 AM

Akesos PCSK9 Monoclonal Antibody Ebronucimab Early Completion Of Patient Enrollment In A Phase III Clinical Trial For Primary Hypercholesterolemia And
December 24,2021 10:08 AM

DBV Plans New Trial, Pulls EU Filing For Peanut Allergy Treatment
December 22,2021 10:54 AM

Amgens Otezla Bags Expanded FDA Nod In Psoriasis; I-Mab CEO Hits The Exit Amid Shakeup At Chinese Firm
December 22,2021 10:21 AM

First Patient Dosed In Australia In ATG-101 First-in-Human Trial
December 21,2021 10:50 AM

Glycomine Begins Patient Dosing In Phase 1 Study Of GLM101 For Treatment Of PMM2-CDG
December 21,2021 10:04 AM

Kura Oncology Doses First Subject In Phase I/II HNSCC Drug Trial
December 20,2021 11:16 AM

Navidea Biopharmaceuticals Announces Launch Of Phase 3 Clinical Trial In Rheumatoid Arthritis
December 20,2021 10:33 AM

GSK, Sanofi Announce Positive Preliminary Booster Data For Covid-19 Vaccine Candidate And Continuation Of Phase III Trial Per Independent DSMB Recomme
December 16,2021 10:31 AM

Zydus Cadila Gets Nod For Phase 2 Clinical Study In CAPS Patients In Australia
December 15,2021 10:11 AM

ACELYRIN INC. Affibody AB And Inmagene Biopharmaceuticals Announce Positive Interim Results From Global Phase 2 Trial Of Izokibep In Patients With Pso
December 15,2021 10:04 AM

Zydus To Initiate Phase II (a) Trial Of ZYIL1 In Patients With CAPS In Australia
December 14,2021 10:03 AM

Aligos Therapeutics Starts Patient Dosing In Phase 1 Study With NASH Drug Candidate, ALG-055009
December 13,2021 10:20 AM

Zydus Gets US FDA Nod To Begin EPICS-III Phase 2 Trial Of Saroglitazar Mg To Treat Primary Biliary Cholangitis
December 11,2021 09:58 AM

Biocytogen Eucure Biopharma Announce The Completion Of First Patient Dosing For Phase I Clinical Trial Of YH004 Anti-4-1BB Monoclonal Antibody In Aust
December 10,2021 10:19 AM

Hutchmed Completes Patient Enrollment Of FRESCO-2 In Phase III Trial Of Fruquintinib In Metastatic Colorectal Cancer
December 09,2021 10:01 AM

Hummingbird Bioscience Announces First Patient Dosed In Phase 1 Clinical Trail Of HMBD-001
December 08,2021 09:53 AM

HUTCHMED Completes Planned Enrollment Of FRESCO-2, A Global Phase III Trial Of Fruquintinib In Metastatic Colorectal Cancer
December 07,2021 09:56 AM

Bayer And Orions Nubeqa Phase III ARASENS Trial In Metastatic Hormone-sensitive Prostate Cancer Meets Primary Endpoint
December 06,2021 11:04 AM

I Mab Announces First Two Patients Dosed In US Phase 2 Combination Trial Of Uliledlimab With Atezolizumab In Patients With Selected Advanced Solid Tum
December 06,2021 10:58 AM

Blade Therapeutics Announces Positive Results From Phase 1 Study Of Cudetaxestat To Treat Idiopathic Pulmonary Fibrosis
December 03,2021 10:10 AM

Revelation Biosciences Inc. Announces Initiation Of A Phase 2b Study To Assess Efficacy Of Intranasal REVTx-99 For The Prevention Of H3N2 Influenza
December 02,2021 10:11 AM

Lynk Pharmaceuticals Announced First Patient Dosed In Phase II Clinical Study Of LNK01001
December 02,2021 09:56 AM

BrainStorm Cell Therapeutics Announces The Presentation Of New Analyses From The Phase 3 Trial Of NurOwn® In ALS At The 4th Annual ALS ONE Research S
November 30,2021 10:07 AM

Starpharma Announces Positive Interim Results From Phase 2 Trial Of DEP Cabazitaxel To Treat Metastatic Prostate Cancer
November 29,2021 09:53 AM

Antengene Announces IND Approval In China For A Phase I/II Study Of Selinexor (ATG-010) In Patients With Non-Hodgkin Lymphoma
November 26,2021 10:22 AM

Transgene NEC Announce Positive Data From Phase I Studies Of TG4050 A Novel Individualized Neoantigen Cancer Vaccine
November 25,2021 10:28 AM

Akston Biosciences Begins Patient Dosing In Phase II Trial Of Covid-19 Vaccine Candidate, AKS-452 In India
November 24,2021 09:54 AM

BeiGene Begins Patient Dosing In Phase 1 Trial Of Investigational TYK2 Inhibitor BGB-23339
November 24,2021 09:53 AM

Arctic Vision Announces First Patient Dosed In Phase III Study Of ARVN001 For Treatment Of Macular Edema Associated With Uveitis (UME)
November 23,2021 10:24 AM

Daiichi Sankyo Begins Patient Dosing In TROPION-Breast01 Phase 3 Trial Of Datopotamab Deruxtecan In Patients With HR Positive, HER2 Negative Metastati
November 22,2021 09:54 AM

PolyPid Announces 500th Patient Enrolled In SHIELD I Phase 3 Clinical Trial Of D-PLEX₁₀₀ In Abdominal Surgery
November 19,2021 10:28 AM

Daiichi Sankyo Begins Patient Dosing In Phase 2 Trial Of MRNA Vaccine DS 5670 Against Covid-19
November 18,2021 10:16 AM

Gannex Gets China NMPA Nod For Phase II And III Protocols Of ASC42 To Treat Primary Biliary Cholangitis
November 17,2021 10:05 AM

GSK Vir Biotech Announce COMET TAIL Phase III Trial Of IV Administration Of Sotrovimab For Early Treatment Of Covid-19 Meets Primary Endpoint
November 16,2021 10:02 AM

DURECT Corporation Doses First Ex US Patient In Phase 2b AHFIRM Study Of Larsucosterol (DUR-928) In Severe Alcohol Associated Hepatitis
November 15,2021 10:45 AM

Kintor Pharma Announces Dosing Of First Patient In Phase II Clinical Trial Of KX-826 For The Treatment Of Androgenic Alopecia Female Patients In China
November 13,2021 10:14 AM

Biological E Soon To Get EUA For Corbevax Covid Vaccine As It Successfully Completes Phase-2 & 3 Clinical Trials
November 12,2021 10:05 AM

Neuroplast Announces Positive Results From Phase I Trial With Neuro-Cells Stem Cell Treatment For Traumatic Spinal Cord Injury
November 11,2021 09:56 AM

Ionis Pharma Announces Positive Results From Phase 2 Study Of Antisense Medicine Donidalorsen
November 10,2021 09:58 AM

Sustained Hepatitis B Surface Antigen Loss In Chronic Hepatitis B Patients With Subcutaneous PD-L1 Antibody ASC22 Treatment: Interim Results Of Phase
November 09,2021 10:24 AM

Hyloris Pharma Begins Phase 2 Study Of Miconazole-domiphen Bromide Vaginal Cream In Vulvovaginal Candidiasis
November 08,2021 10:29 AM

Hutchmed AstraZeneca Begin SAMETA Phase III Trial Of Savolitinib In Combo With PD-L1 Inhibitor Imfinzi In Patients With MET-driven Advanced PRCC
November 03,2021 09:50 AM

CORRECTING And REPLACING First Patient Dosed In CANbridge Pharmaceuticals CAN008 Phase 2 Trial For Treatment Of Glioblastoma Multiforme GBM In China
November 02,2021 10:11 AM

Novocure Completes Patient Enrollment In Phase 3 Pivotal INNOVATE-3 Trial Of Tumor Treating Fields In Ovarian Cancer
November 01,2021 09:55 AM

GenFleet Announces First Patient Dosed In Phase Ib/II Trial Of TGF-β R1 Inhibitor In Combination With PD-1 Inhibitor In Global Multi-center Research
October 30,2021 10:28 AM

Atamyo Therapeutics Seeks European Approval To Begin Clinical Trial Of Gene Therapy ATA-100 To Treat Limb-girdle Muscular Dystrophy Type 2I/R9
October 29,2021 10:05 AM

First Patient Dosed In CANbridge Pharmaceuticals CAN008 Phase 2 Trial For Treatment Of Glioblastoma Multiforme (GBM) In China
October 28,2021 09:56 AM

Second Phase 3 Trial Of Dupixent In Patients 12 Years And Older With Eosinophilic Esophagitis Meets Co-primary Endpoints
October 27,2021 09:51 AM

Pfizer And BioNTech Announce Phase 3 Trial Data Showing High Efficacy Of A Booster Dose Of Their COVID-19 Vaccine
October 26,2021 09:47 AM

Zydus Begins Patient Dosing In EVIDENCES-X Phase II(b) Trial Of Saroglitazar Mg To Treat NASH
October 25,2021 09:52 AM

Daiichi Sankyo Takes Oncology Shift Into Next Phase With New Global Business Unit
October 23,2021 10:38 AM

AstraZenecas Phase III TULIP 2 Trial Of Anifrolumab To Treat Systemic Lupus Erythematosus Meets Primary Endpoint
October 22,2021 09:55 AM

GenFleet Announces First Patient Dosed In Phase Ib/II Trial Of TGF-β R1 Inhibitor In Combination With PD-1 Inhibitor In Global Multi-center Research
October 21,2021 10:44 AM

Phase 3 COV-COMPARE Trial Of Covid-19 Vaccine Developed By Valneva Using Dynavaxs CpG 1018 Adjuvant Meets Both Co-primary Endpoints
October 20,2021 09:39 AM

Protalix Biotherapeutics And Chiesi Global Rare Diseases Announce Final Dosing Of Last Patient In Phase III BALANCE Clinical Trial PRX-102 For The Tre
October 19,2021 10:56 AM

FDA Awards 11 Grants To Clinical Trials To Develop New Medical Products For Rare Disease Treatments
October 18,2021 09:46 AM

Innovent Announces First Patient Dosed In A Phase 2 Clinical Trial Of IBI112 (IL-23 Monoclonal Antibody) In Patients With Moderate-to-severe Plaque Ps
October 14,2021 10:05 AM

Biological E Seeks DCGIs Nod For Phase-3 Trial Of Corbevax As Booster Dose In Those Vaccinated With Covishield Or Covaxin
October 13,2021 09:56 AM

Phase II Clinical Trial Of Niclosamide Drug For Treatment Of Covid-19 Patients Begins
October 12,2021 09:48 AM

Lutris Pharma Initiates Part Two Of Its Phase 1/2 Trial Of LUT014 To Treat Radiation Dermatitis In Breast Cancer Patients
October 08,2021 09:52 AM

Harbour BioMed Announces Dosing Of First Patient Of Batoclimab Phase III Trial In Patients With Generalized Myasthenia Gravis
October 07,2021 09:55 AM

Cadila Healthcare Gets DCGI Nod To Conduct Phase III Trials For Two-dose Covid Vaccine
October 06,2021 09:27 AM

BioNTech Begins Patient Dosing In Phase 2 Trial Of MRNA-based Individualized Immunotherapy BNT122 In Colorectal Cancer Patients
October 05,2021 09:43 AM

Edison Oncology And Apollomics Inc Announce Treatment Of First Patient For EO1001 APL-122 In A Phase I/IIa Clinical Trial
October 04,2021 09:41 AM

China NMPA Accepts I-Mabs IND Application To Begin Phase 2 Trial Of Enoblituzumab In Combo With Keytruda To Treat Solid Tumors
October 01,2021 09:51 AM

Pfizer, BioNTech Submit Initial Data To US FDA From Phase 2/3 Trial Of Covid-19 Vaccine In Children 5 To 12 Years Of Age
September 30,2021 09:30 AM

GNT Pharma Announces Approval Of IND Application For The Phase III RODIN Trial Of Nelonemdaz For Acute Ischemic Stroke Patients
September 29,2021 09:41 AM

Harbour BioMed Announces Dosing Of First Patient Of Batoclimab Phase III Trial In Patients With Generalized Myasthenia Gravis
September 28,2021 09:37 AM

Innovent Announces First Patient Dosed In A Phase 2 Clinical Trial Of IBI112 (IL-23 Monoclonal Antibody) In Patients With Moderate-to-severe Plaque Ps
September 27,2021 09:48 AM

First Patient Randomized In Tarsier Pharmas TRS4VISION Phase-III Clinical Trial In Patients With Active Non-Infectious Anterior Uveitis Including Pati
September 24,2021 09:31 AM

Bayer Initiates Phase III FIND-CKD Study Of Kerendia To Investigate Use In Patients With Nondiabetic Chronic Kidney Disease
September 23,2021 09:32 AM

Harbour BioMed Announces IND Approval For Phase II Trial Of Anti-FcRn Batoclimab In Chronic Inflammatory Demyelinating Polyneuropathy In China
September 22,2021 09:44 AM

HUTCHMED Initiates SURTORI-01, A Phase III Trial Of SULANDA® In Combination With TUOYI® In The Treatment Of Advanced Neuroendocrine Carcinoma In Chi
September 21,2021 09:23 AM

Novartis To Present Positive Results From Phase III VISION Study Of 177Lu-PSMA-617 Radioligand Therapy In Patients With Advanced Prostate Cancer At ES
September 20,2021 09:22 AM

The NDA Of Henlius Novel Anti-PD-1 MAb Serplulimab For First-Line Treatment Of SqNSCLC Accepted By Chinas NMPA Phase 3 MRCT Met Its Primary Endpoint
September 18,2021 09:45 AM

Biophytis To Continue Phase II/III Covid-19 Drug Trial Without Changes
September 17,2021 09:35 AM

Biosplice Licenses Development And Commercialization Rights For Lorecivivint A Novel Phase 3 Osteoarthritis Drug Candidate To Haisco For The Peoples R
September 16,2021 09:54 AM

AzurRx Expands Phase II Covid-19 Trial Of Niclosamide To India
September 15,2021 10:13 AM

Hutchmed & AstraZeneca Initiate SANOVO Phase III Study Of Orpathys In Combo With Tagrisso To Treat Certain NSCLC Patients In China
September 14,2021 09:35 AM

Hutchmed & AstraZeneca Initiate SANOVO Phase III Study Of Orpathys In Combo With Tagrisso To Treat Certain NSCLC Patients In China
September 13,2021 09:32 AM

Bharats Intranasal Vaccine Speeds Into Phase II On Heels Of Strong Data
September 11,2021 10:03 AM

China Completes Largest Ever Dry Eye Disease Clinical Trial
September 11,2021 10:02 AM

Ascendis Seeks US FDA Nod To Begin Phase 1/2 Trial Of TransCon IL-2 ß To Treat Advanced Cancer
September 10,2021 09:48 AM

Kintor Pharma Announces The Primary Endpoint Of Phase II Clinical Study For KX-826s Treatment Of Androgenetic Alopecia Was Met
September 09,2021 09:26 AM

First-in-human Clinical Trial For A Vaccine To Treat Opioid Use Disorders Enrolls First Patients
September 09,2021 09:26 AM

KAHR Announces FDA Clearance Of IND Application For Phase 1b Trial Of Its Lead Anti-CD47 Candidate In Blood Cancers
September 07,2021 09:24 AM

Takeda Blood Cancer Drug Fails In Phase III
September 06,2021 09:37 AM

Merck And Ridgeback Begin Phase III Trial Of Molnupiravir For Covid-19
September 04,2021 10:45 AM

Arctic Vision Obtains China IND Clearance For Phase III Study Of ARVN003, The First In China For Presbyopia Treatment
September 04,2021 10:42 AM

Dupixent® Reduces Atopic Dermatitis By 70 Percent In Phase III Trial
September 03,2021 09:46 AM

Takeda Blood Cancer Drug Fails In Phase III
September 03,2021 09:33 AM

Sanofis Phase 3 Trial Of Dupixent To Treat Atopic Dermatitis Meets All Primary And Secondary Endpoints
September 01,2021 10:48 AM

SK Bioscience & GSK Initiate Phase 3 Trial Of Adjuvanted Covid-19 Vaccine Candidate
September 01,2021 10:46 AM

Alexions Drug Meets Primary Goal In Phase III Wilson Disease Trial
August 31,2021 09:16 AM

Novartis Phase III ORION Leqvio Analyses Show Effective And Sustained LDL-C Reduction In Two Sub-populations Of Patients With ASCVD
August 31,2021 09:12 AM

ICR And Nuvectis To Begin Phase I Trial Of Novel Drug For Cancer Treatment
August 28,2021 10:40 AM

Gennova Vax Gets Nod For Ph 2/3 Trials
August 27,2021 10:38 AM

Bharat Biotechs Covaxin Approved For Phase 2/3 Trials On Children
July 19,2021 02:42 PM

Categories

Approval
Licensing Deal
New Indication Trial
Discontinued/Warning
Clinical Trial Update
Acquisition/Merger
Odd/Bta
Patent

Clinical trials data Insight on over 3,00,000 clinical trials from Phase 0 to IV across all indication includes, Orphan disease and Therapy Area.

Terms & Conditions | Privacy Policy | Disclaimer | Sitemap

Quick Links

About Us
Contact us
Pricing
Licensing Opportunities
CRO
Refund Policy

C-89 1st Floor, Sector-65 Noida-U.P. 201301 (India)

INDIA : +91-120-6631301-335

US : +1-201-688-7280

sales@lifescienceintellipedia.com

info@lifescienceintellipedia.com

© Copyright 2021 All right reserved, Lifescience Intellipedia Pvt. Ltd.